© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
September 23, 2021
IDP-126, an acne vulgaris treatment for patients ages 9 and older, met all of its endpoints in a 12-week phase 3 study.
September 13, 2021
New targeted therapies known as PARP inhibitors (PARPis) used to treat patients with advanced ovarian cancer are transforming the treatment landscape through precision medicine.
September 08, 2021
The National Medical Products Administration in China has approved pembrolizumab for use in combination with platinum and fluoropyrimidine-based chemotherapy for the frontline treatment of patients.
July 29, 2021
The American Heart Association recently released new findings on 2 classes of blood pressure medications.
July 23, 2021
Patients with diabetes and depression may have a lower risk of mortality and diabetes complications when taking antidepressants regularly, according to a new study.
July 21, 2021
Drug overdose deaths, including opioid-related deaths, have increased rapidly in the United States in recent years, according to preliminary data from the CDC.
July 20, 2021
Dapagliflozin was shown to significantly reduce the risk of kidney failure and prolong survival in patients with advanced chronic kidney disease regardless of diabetes status.
July 13, 2021
A new medication called finerenone (Kerendia; Bayer) has been approved for the treatment of kidney disease and type 2 diabetes.
May 04, 2021
More opportunities are emerging for pharmacists to fine-tune their patients’ regimens and serve as important access points for individuals experiencing mental health crises.
April 20, 2021
The study will be presented today during the 2021 American Academy of Neurology Annual Meeting.